Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06885177 · ClinicalTrials.gov registry record · NA

TECTONIC CAD IVL IDE Study

A NA study of Coronary Artery Disease and Coronary Artery Calcification, sponsored by Abbott Medical Devices.

Recruiting
Registry status
NA
Development phase
335
Enrollment target
20
Study locations

NCT06885177: Recruiting NA study of Coronary Artery Disease and Coronary Artery Calcification, sponsored by Abbott Medical Devices.

NCT06885177 is a NA study of Coronary Artery Disease and Coronary Artery Calcification that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 335 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06885177, a NA study of Coronary Artery Disease and Coronary Artery Calcification, is actively recruiting participants, sponsored by Abbott Medical Devices.

RECRUITING
Registry status
NA
Development phase
335 participants
Enrollment target
20
Study locations

Study Summary

A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

Primary Outcome

The primary effectiveness endpoint is procedural success that is defined as stent delivery with final mean residual stenosis \<50% (core laboratory assessed) and without in-hospital TLF.

Conditions Studied

Coronary Artery Disease Coronary Artery Calcification Stenotic Coronary Lesion

Interventions

  • DEVICE Experimental

Study Locations (20)

Florida

  • The Cardiac & Vascular Institute Research Foundation, LLC - Gainesville
  • UF Health Jacksonville - Jacksonville
  • Mayo Clinic of Jacksonville - Jacksonville
  • First Coast Cardiovascular Institute - Jacksonville
  • Mt. Sinai Medical Center - Miami Beach
  • AdventHealth Orlando - Orlando
  • University of South Florida - Tampa
  • AdventHealth Tampa - Tampa

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University Hospital - Atlanta
  • Wellstar Kennestone Regional Medical Center - Marietta

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Endeavor Health - Evanston
  • Carle Foundation Hospital - Urbana

Arizona

  • HonorHealth - Scottsdale

Arkansas

  • Arkansas Heart Hospital - Little Rock

California

  • Kaiser Permanente - San Francisco - San Francisco

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Kansas

  • Via Christi Regional Medical Center - St. Francis Campus - Wichita

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 2025-04-01
Est. Completion 2028-06
Phase NA
Abbott Medical Devices

261 total trials

What NCT06885177 shows while recruiting

NCT06885177 is an interventional study that assigns participants to a tested intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower).

The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Experimental is the first listed.

NCT06885177 names 20 study sites across 9 states, led by Florida, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT06885177 about?

NCT06885177 is a clinical study titled "TECTONIC CAD IVL IDE Study". A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

What is the current status of trial NCT06885177?

This trial is currently recruiting. It is a NA study. The enrollment target is 335 participants. The study started on 2025-04-01. Estimated completion is 2028-06.

What conditions does trial NCT06885177 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Coronary Artery Calcification, Stenotic Coronary Lesion.

What interventions are being tested in trial NCT06885177?

The interventions under investigation include: Experimental (DEVICE).

Who is sponsoring clinical trial NCT06885177?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06885177 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06885177's enrollment target sits among peer trials

335 98th of 219 higher than 122 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04134754 · 335 participants · NA

    Carbon Dioxide (CO2) Chemosensitivity and SUDEP

  • NCT05554406 · 335 participants · Phase 2

    Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  • NCT06183437 · 335 participants · Phase 4

    The STOP-MED CTRCD Trial

  • NCT03947385 · 336 participants · Phase 1

    Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06885177

Source: ClinicalTrials.gov NCT06885177, the US trial registry maintained by the National Library of Medicine. NCT06885177 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.